Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,034.23 10.14 (0.99%) as of 4:30 Fri 7/5


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 108.27(B)
Last Volume: 418,302 Avg Vol: 758,271
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,995 237,237 312,646 469,880
Total Sell Value $189,656,342 $231,855,596 $295,997,978 $406,115,303
Total People Sold 7 13 16 18
Total Sell Transactions 18 40 67 129
End Date 2024-04-07 2024-01-05 2023-07-07 2022-07-07

   
Records found: 2433
  Page 79 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Roberts William VP Regul Devel & Med Safety   •       –      –    2011-01-14 4 AS $33.99 $197,566 D/D (5,795) 66,956     -
   Roberts William VP Regul Devel & Med Safety   •       –      –    2011-01-14 4 OE $9.49 $11,274 D/D 1,188 68,144     -
   Vagelos P Roy Chairman of the Board   •       •      –    2011-01-12 4 GA $0.00 $0 I/I 1,203 1,203     -
   Vagelos P Roy Chairman of the Board   •       •      –    2011-01-12 4 GD $0.00 $0 D/D 1,203 109,309     -
   Roberts William VP Regul Devel & Med Safety   •       –      –    2011-01-07 4 D $34.17 $184,279 D/D (5,393) 71,563     -
   Roberts William VP Regul Devel & Med Safety   •       –      –    2011-01-07 4 OE $9.49 $94,900 D/D 10,000 76,956     -
   Goldberg Murray A SVP F&A, CFO, Treas & Asst Sec   •       –      –    2011-01-07 4 AS $33.95 $251,365 D/D (7,373) 77,734     -
   Vagelos P Roy Director   –       •      –    2011-01-06 4 AS $34.04 $716,304 D/D (21,043) 110,512     -
   Goldberg Murray A SVP F&A, CFO, Treas & Asst Sec   •       –      –    2011-01-06 4 D $33.79 $426,666 D/D (12,627) 85,107     -
   Goldberg Murray A SVP F&A, CFO, Treas & Asst Sec   •       –      –    2011-01-06 4 OE $13.00 $285,347 D/D 20,000 87,979     -
   Vagelos P Roy Director   –       •      –    2011-01-04 4 GD $0.00 $0 I/I 6,311 183,808     -
   Vagelos P Roy Director   –       •      –    2011-01-03 4 AS $34.04 $304,896 D/D (8,957) 131,555     -
   Goldberg Murray A SVP F&A, CFO, Treas & Asst Sec   •       –      –    2010-12-23 4 OE $9.49 $37,960 D/D 4,000 77,734     -
   Brown Michael S Director   –       •      –    2010-12-22 4 GD $0.00 $0 D/D 5,000 24,662     -
   Brown Michael S Director   –       •      –    2010-12-20 4 AS $32.89 $69,869 D/D (2,103) 29,662     -
   Goldstein Joseph L Director   –       •      –    2010-12-17 4 AS $32.00 $168,992 D/D (5,281) 0     -
   Brown Michael S Director   –       •      –    2010-12-17 4 D $32.44 $93,979 D/D (2,897) 31,765     -
   Brown Michael S Director   –       •      –    2010-12-17 4 OE $18.80 $94,000 D/D 5,000 34,662     -
   Vagelos P Roy Director   –       •      –    2010-12-17 4 AS $32.06 $404,469 D/D (12,616) 140,512     -
   Goldberg Murray A SVP F&A, CFO, Treas & Asst Sec   •       –      –    2010-12-17 4 AS $32.15 $166,151 D/D (5,168) 43,734     -
   Van Plew Daniel P SVP & GM, Indust Ops&Prod Supp   •       –      –    2010-12-16 4 AS $32.00 $800,000 D/D (25,000) 0     -
   Van Plew Daniel P SVP & GM, Indust Ops&Prod Supp   •       –      –    2010-12-16 4 OE $20.90 $522,500 D/D 25,000 15,432     -
   Goldstein Joseph L Director   –       •      –    2010-12-16 4 D $31.80 $150,064 D/D (4,719) 5,281     -
   Goldstein Joseph L Director   –       •      –    2010-12-16 4 OE $15.01 $150,100 D/D 10,000 10,000     -
   Vagelos P Roy Director   –       •      –    2010-12-16 4 AS $32.04 $556,983 D/D (17,384) 153,128     -
  2433 Records found
  Previous  70  71  72  73  74  75  76  77  78  79  Next   
  Page 79 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us